ASPH

ASPH
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	5APA
Identifiers
Aliases	ASPH, AAH, BAH, CASQ2BP1, FDLAB, HAAH, JCTN, junctin, aspartate beta-hydroxylase
External IDs	OMIM: 600582; MGI: 1914186; HomoloGene: 20910; GeneCards: ASPH; OMA:ASPH - orthologs
EC number	1.14.11.16
Gene location (Human)
Chr.	Chromosome 8 (human)
End	61,714,640 bp
Gene location (Mouse)
Chr.	Chromosome 4 (mouse)
End	9,669,344 bp
RNA expression pattern
	Top expressed in
	Achilles tendon; ; stromal cell of endometrium; ; palpebral conjunctiva; ; epithelium of colon; ; islet of Langerhans; ; right adrenal cortex; ; left adrenal gland; ; germinal epithelium; ; left adrenal cortex; ; adipose tissue;
	Top expressed in
	vastus lateralis muscle; ; triceps brachii muscle; ; temporal muscle; ; tibialis anterior muscle; ; sternocleidomastoid muscle; ; medial head of gastrocnemius muscle; ; muscle of thigh; ; soleus muscle; ; digastric muscle; ; interventricular septum;
	More reference expression data
	; ; ; ;
	More reference expression data
Gene ontology
Molecular function	transmembrane transporter binding; dioxygenase activity; structural molecule activity; metal ion binding; protein binding; electron transfer activity; oxidoreductase activity; structural constituent of muscle; calcium ion binding; peptidyl-aspartic acid 3-dioxygenase activity;
Cellular component	integral component of membrane; calcium channel complex; membrane; plasma membrane; cortical endoplasmic reticulum; junctional sarcoplasmic reticulum membrane; sarcoplasmic reticulum; integral component of endoplasmic reticulum membrane; sarcoplasmic reticulum membrane; sarcoplasmic reticulum lumen; endoplasmic reticulum membrane; endoplasmic reticulum; cytoplasm;
Biological process	cellular response to calcium ion; positive regulation of intracellular protein transport; regulation of ryanodine-sensitive calcium-release channel activity; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; response to ATP; regulation of cardiac conduction; muscle contraction; positive regulation of calcium ion transport into cytosol; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; peptidyl-amino acid modification; detection of calcium ion; positive regulation of transcription, DNA-templated; positive regulation of ryanodine-sensitive calcium-release channel activity; ion transmembrane transport; activation of cysteine-type endopeptidase activity; calcium ion transmembrane transport; positive regulation of proteolysis; regulation of cell communication by electrical coupling; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; activation of store-operated calcium channel activity; pattern specification process; negative regulation of cell population proliferation; regulation of protein stability; limb morphogenesis; peptidyl-aspartic acid hydroxylation; roof of mouth development; face morphogenesis; regulation of protein depolymerization; electron transport chain;
	Sources:Amigo / QuickGO
Orthologs
	444
	65973
	ENSG00000198363
	ENSMUSG00000028207
	Q12797
	Q8BSY0
NM_001164750; NM_001164751; NM_001164752; NM_001164753; NM_001164754;
	NM_001164755; NM_001164756; NM_004318; NM_020164; NM_032466; NM_032467; NM_032468
NM_001177849; NM_001177850; NM_001177851; NM_001177852; NM_001177853;
	NM_001177854; NM_001177855; NM_001177856; NM_001290367; NM_023066; NM_133723
NP_001158222; NP_001158223; NP_001158224; NP_001158225; NP_001158226;
	NP_001158227; NP_001158228; NP_004309; NP_064549; NP_115855; NP_115856; NP_115857
NP_001171320; NP_001171321; NP_001171322; NP_001171323; NP_001171324;
	NP_001171325; NP_001171326; NP_001171327; NP_001277296; NP_075553; NP_598484
	Wikidata
View/Edit Human	View/Edit Mouse

Aspartyl/asparaginyl beta-hydroxylase (HAAH) is an enzyme that in humans is encoded by the ASPH gene.^[5]^[6]^[7] ASPH is an alpha-ketoglutarate-dependent hydroxylase, a superfamily non-haem iron-containing proteins.

Function

This gene is thought to play an important role in calcium homeostasis. Alternative splicing of this gene results in five transcript variants which vary in protein translation, the coding of catalytic domains, and tissue expression. Variation among these transcripts impacts their functions which involve roles in the calcium storage and release process in the endoplasmic and sarcoplasmic reticulum as well as hydroxylation of aspartic acid and asparagine in epidermal growth factor-like domains of various proteins.^[7]

Clinical significance

As early as 1996, the over-expression of HAAH was recognized as an indicator of carcinoma in humans. Further research has correlated elevated HAAH levels (variously in affected tissue or blood serum) with hepatocellular (liver) carcinoma^[8]^[9] adenocarcinoma (pancreatic cancer),^[10] colorectal cancer,^[11] prostate cancer.^[9] and lung cancer.^[12] The pancreatic study^[10] showed elevated HAAH only in diseased tissue, but not in adjacent normal and inflamed tissue.

Mutations in ASPH cause Traboulsi syndrome.^[13]

References

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000198363 – Ensembl, May 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000028207 – Ensembl, May 2017
^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ Korioth F, Gieffers C, Frey J (December 1994). "Cloning and characterization of the human gene encoding aspartyl beta-hydroxylase". Gene. 150 (2): 395–9. doi:10.1016/0378-1119(94)90460-X. PMID 7821814.
^ Lim KY, Hong CS, Kim DH (September 2000). "cDNA cloning and characterization of human cardiac junctin". Gene. 255 (1): 35–42. doi:10.1016/S0378-1119(00)00299-7. PMID 10974562.
^ ^a ^b "Entrez Gene: ASPH aspartate beta-hydroxylase".
^ Ince N, de la Monte SM, Wands JR (March 2000). "Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation". Cancer Research. 60 (5): 1261–6. PMID 10728685.
^ ^a ^b Xue T, Xue XP, Huang QS, Wei L, Sun K, Xue T (August 2009). "Monoclonal antibodies against human aspartyl (asparaginyl) beta-hydroxylase developed by DNA immunization". Hybridoma. 28 (4): 251–7. doi:10.1089/hyb.2009.0017. PMID 19663697.
^ ^a ^b Palumbo KS, Wands JR, Safran H, King T, Carlson RI, de la Monte SM (July 2002). "Human aspartyl (asparaginyl) beta-hydroxylase monoclonal antibodies: potential biomarkers for pancreatic carcinoma". Pancreas. 25 (1): 39–44. doi:10.1097/00006676-200207000-00010. PMID 12131769. S2CID 2098747.
^ "CC Detect - Serum-Based Diagnostic Test For Colon Cancer Available". Archived from the original on 2021-02-08. Retrieved 2011-11-29.
^ Hampton T (November 2007). "New screening techniques show potential for early detection of lung cancer". JAMA. 298 (17): 1997. doi:10.1001/jama.298.17.1997. PMID 17986689.
^ Patel N, Khan AO, Mansour A, Mohamed JY, Al-Assiri A, Haddad R, et al. (May 2014). "Mutations in ASPH cause facial dysmorphism, lens dislocation, anterior-segment abnormalities, and spontaneous filtering blebs, or Traboulsi syndrome". American Journal of Human Genetics. 94 (5): 755–9. doi:10.1016/j.ajhg.2014.04.002. PMC 4067561. PMID 24768550.

External links

Human ASPH genome location and ASPH gene details page in the UCSC Genome Browser.
Overview of all the structural information available in the PDB for UniProt: Q12797 (Aspartyl/asparaginyl beta-hydroxylase) at the PDBe-KB.

Hirota K, Semenza GL (December 2005). "Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases". Biochemical and Biophysical Research Communications. 338 (1): 610–6. doi:10.1016/j.bbrc.2005.08.193. PMID 16154531.
Lavaissiere L, Jia S, Nishiyama M, de la Monte S, Stern AM, Wands JR, Friedman PA (September 1996). "Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma". The Journal of Clinical Investigation. 98 (6): 1313–23. doi:10.1172/JCI118918. PMC 507557. PMID 8823296.
Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR (September 1997). "Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane". The Journal of Biological Chemistry. 272 (37): 23389–97. doi:10.1074/jbc.272.37.23389. PMID 9287354.
Wetzel GT, Ding S, Chen F (March 2000). "Molecular cloning of junctin from human and developing rabbit heart". Molecular Genetics and Metabolism. 69 (3): 252–8. doi:10.1006/mgme.2000.2966. PMID 10767180.
Dinchuk JE, Henderson NL, Burn TC, Huber R, Ho SP, Link J, et al. (December 2000). "Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin". The Journal of Biological Chemistry. 275 (50): 39543–54. doi:10.1074/jbc.M006753200. PMID 10956665.
Treves S, Feriotto G, Moccagatta L, Gambari R, Zorzato F (December 2000). "Molecular cloning, expression, functional characterization, chromosomal localization, and gene structure of junctate, a novel integral calcium binding protein of sarco(endo)plasmic reticulum membrane". The Journal of Biological Chemistry. 275 (50): 39555–68. doi:10.1074/jbc.M005473200. PMID 11007777.
Kirchhefer U, Neumann J, Baba HA, Begrow F, Kobayashi YM, Reinke U, et al. (February 2001). "Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1". The Journal of Biological Chemistry. 276 (6): 4142–9. doi:10.1074/jbc.M006443200. PMID 11069905.
Sepe PS, Lahousse SA, Gemelli B, Chang H, Maeda T, Wands JR, de la Monte SM (July 2002). "Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility". Laboratory Investigation; A Journal of Technical Methods and Pathology. 82 (7): 881–91. doi:10.1097/01.lab.0000020406.91689.7f. PMID 12118090.
Ho SP, Scully MS, Krauthauser CM, Wexler EJ, Stow MD, Dinchuk JE, et al. (August 2002). "Antisense oligonucleotides selectively regulate aspartyl beta-hydroxylase and its truncated protein isoform in vitro but distribute poorly into A549 tumors in vivo". The Journal of Pharmacology and Experimental Therapeutics. 302 (2): 795–803. doi:10.1124/jpet.302.2.795. PMID 12130746. S2CID 7167890.
Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, et al. (December 2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proceedings of the National Academy of Sciences of the United States of America. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
Maeda T, Sepe P, Lahousse S, Tamaki S, Enjoji M, Wands JR, de la Monte SM (May 2003). "Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells". Journal of Hepatology. 38 (5): 615–22. doi:10.1016/S0168-8278(03)00052-7. PMID 12713872.
Treves S, Franzini-Armstrong C, Moccagatta L, Arnoult C, Grasso C, Schrum A, et al. (August 2004). "Junctate is a key element in calcium entry induced by activation of InsP3 receptors and/or calcium store depletion". The Journal of Cell Biology. 166 (4): 537–48. doi:10.1083/jcb.200404079. PMC 1868564. PMID 15302852.
Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, Li J, et al. (August 2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins". Proceedings of the National Academy of Sciences of the United States of America. 101 (33): 12130–5. Bibcode:2004PNAS..10112130B. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
Xian ZH, Zhang SH, Cong WM, Yan HX, Wang K, Wu MC (February 2006). "Expression of aspartyl beta-hydroxylase and its clinicopathological significance in hepatocellular carcinoma". Modern Pathology. 19 (2): 280–6. doi:10.1038/modpathol.3800530. PMID 16341145.
de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, Carter JJ, et al. (May 2006). "Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness". Journal of Hepatology. 44 (5): 971–83. doi:10.1016/j.jhep.2006.01.038. PMID 16564107.
Feldmann G, Nattermann J, Nischalke HD, Gorschlüter M, Kuntzen T, Ahlenstiel G, et al. (June 2006). "Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer". Endoscopy. 38 (6): 604–9. doi:10.1055/s-2006-925065. PMID 16673309. S2CID 33900440.
Gundogan F, Elwood G, Greco D, Rubin LP, Pinar H, Carlson RI, et al. (January 2007). "Role of aspartyl-(asparaginyl) beta-hydroxylase in placental implantation: Relevance to early pregnancy loss". Human Pathology. 38 (1): 50–9. doi:10.1016/j.humpath.2006.06.005. PMID 16949909.

This article on a gene on human chromosome 8 is a stub. You can help Wikipedia by expanding it.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000198363 – Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000028207 – Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[pmid7821814-5] Korioth F, Gieffers C, Frey J (December 1994). "Cloning and characterization of the human gene encoding aspartyl beta-hydroxylase". Gene. 150 (2): 395–9. doi:10.1016/0378-1119(94)90460-X. PMID 7821814.

[pmid10974562-6] Lim KY, Hong CS, Kim DH (September 2000). "cDNA cloning and characterization of human cardiac junctin". Gene. 255 (1): 35–42. doi:10.1016/S0378-1119(00)00299-7. PMID 10974562.

[entrez-7] "Entrez Gene: ASPH aspartate beta-hydroxylase".

[Ince_2000-8] Ince N, de la Monte SM, Wands JR (March 2000). "Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation". Cancer Research. 60 (5): 1261–6. PMID 10728685.

[Xue_2009-9] Xue T, Xue XP, Huang QS, Wei L, Sun K, Xue T (August 2009). "Monoclonal antibodies against human aspartyl (asparaginyl) beta-hydroxylase developed by DNA immunization". Hybridoma. 28 (4): 251–7. doi:10.1089/hyb.2009.0017. PMID 19663697.

[Palumbo_2002-10] Palumbo KS, Wands JR, Safran H, King T, Carlson RI, de la Monte SM (July 2002). "Human aspartyl (asparaginyl) beta-hydroxylase monoclonal antibodies: potential biomarkers for pancreatic carcinoma". Pancreas. 25 (1): 39–44. doi:10.1097/00006676-200207000-00010. PMID 12131769. S2CID 2098747.

[urlCC_Detect_-_Serum-Based_Diagnostic_Test_For_Colon_Cancer_Available-11] "CC Detect - Serum-Based Diagnostic Test For Colon Cancer Available". Archived from the original on 2021-02-08. Retrieved 2011-11-29.

[pmid17986689-12] Hampton T (November 2007). "New screening techniques show potential for early detection of lung cancer". JAMA. 298 (17): 1997. doi:10.1001/jama.298.17.1997. PMID 17986689.

[13] Patel N, Khan AO, Mansour A, Mohamed JY, Al-Assiri A, Haddad R, et al. (May 2014). "Mutations in ASPH cause facial dysmorphism, lens dislocation, anterior-segment abnormalities, and spontaneous filtering blebs, or Traboulsi syndrome". American Journal of Human Genetics. 94 (5): 755–9. doi:10.1016/j.ajhg.2014.04.002. PMC 4067561. PMID 24768550.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

v t e Oxidoreductases: dioxygenases, including steroid hydroxylases (EC 1.14)
1.14.11: 2-oxoglutarate	Prolyl hydroxylase HIF prolyl-hydroxylase EGLN1 EGLN2 EGLN3 P4HTM Lysyl hydroxylase AlkB ALKBH1 FTO
1.14.13: NADH or NADPH	Flavin-containing monooxygenase FMO1 FMO2 FMO3 FMO4 FMO5 Nitric oxide synthase NOS1 NOS2 NOS3 Cholesterol 7 alpha-hydroxylase Methane monooxygenase 3A4 14α-demethylase 24-hydroxycholesterol 7α-hydroxylase
1.14.14: reduced flavin or flavoprotein	19A1 2D6 2E1
1.14.15: reduced iron–sulfur protein	11B1 11B2 11A1
1.14.16: reduced pteridine (BH4 dependent)	Phenylalanine hydroxylase Tyrosine hydroxylase Tryptophan hydroxylase
1.14.17: reduced ascorbate	Dopamine beta-hydroxylase
1.14.18-19: other	Tyrosinase Stearoyl-CoA desaturase-1
1.14.99 - miscellaneous	Cyclooxygenase Heme oxygenase (HMOX1) Squalene monooxygenase 17A1 21A2 Ecdysone 20-monooxygenase Deoxyhypusine monooxygenase

v t e Enzymes
Activity	Active site Binding site Catalytic triad Oxyanion hole Enzyme promiscuity Diffusion-limited enzyme Cofactor Enzyme catalysis
Regulation	Allosteric regulation Cooperativity Enzyme inhibitor Enzyme activator
Classification	EC number Enzyme superfamily Enzyme family List of enzymes
Kinetics	Enzyme kinetics Eadie–Hofstee diagram Hanes–Woolf plot Lineweaver–Burk plot Michaelis–Menten kinetics
Types	EC1 Oxidoreductases (list) EC2 Transferases (list) EC3 Hydrolases (list) EC4 Lyases (list) EC5 Isomerases (list) EC6 Ligases (list) EC7 Translocases (list)

Function

Clinical significance

References

External links

Further reading